{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:38:50Z","timestamp":1774276730167,"version":"3.50.1"},"reference-count":36,"publisher":"Informa UK Limited","issue":"16","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.4155\/fmc-2017-0115","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T13:19:22Z","timestamp":1509110362000},"page":"1899-1912","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["Discovery of a Cox-2 Selective Inhibitor Hit with Anti-Inflammatory Activity and Gastric Ulcer Protective Effect"],"prefix":"10.1080","volume":"9","author":[{"given":"Mohamed A","family":"Abdelgawad","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt"},{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, Aljouf University, Sakaka, Aljouf2014, Kingdom of Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania B","family":"Bakr","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt"},{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, Aljouf University, Sakaka, Aljouf2014, Kingdom of Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed O","family":"El-Gendy","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gehan M","family":"Kamel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Cairo11561, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany A","family":"Azouz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Nasir Abbas","family":"Bukhari","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, Aljouf University, Sakaka, Aljouf2014, Kingdom of Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00203-9"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.18433\/J3T886"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.12.12.1063"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.24.11693"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/9550"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(99)00147-X"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.8.954"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70334-3"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.8.3228"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.25.12013"},{"issue":"19","key":"e_1_3_3_13_1","first-page":"5405","article-title":"Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)\/neu-induced breast cancer","volume":"62","author":"Howe LR","year":"2002","unstructured":"Howe LR , SubbaramaiahK, PatelJet al. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)\/neu-induced breast cancer. Cancer Res.62 (19), 5405\u20135407 (2002).","journal-title":"Cancer Res."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.01.064"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm990577v"},{"issue":"3","key":"e_1_3_3_16_1","first-page":"395","article-title":"The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk","volume":"27","author":"Greenberg J","year":"2009","unstructured":"Greenberg J , FisherM, KremerJet al. The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk. Clin. Exp. Rheumatol.27 (3), 395 (2009).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.05.093"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2010.08.008"},{"key":"e_1_3_3_19_1","first-page":"109","article-title":"Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives","volume":"1","author":"Terzio\u011flu N","year":"2006","unstructured":"Terzio\u011flu N , Karal\u0131aN, G\u00fcrsoyAet al. Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives. ARKIVOC1, 109\u2013118 (2006).","journal-title":"ARKIVOC"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2011.01149.x"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.02.001"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3998\/ark.5550190.0006.205"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2008.10.032"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.3998\/ark.5550190.0008.e08"},{"issue":"4","key":"e_1_3_3_25_1","first-page":"79","article-title":"Research article, Anti-inflammatory, analgesic and anti ulcer activity of certain thiazolidinones","volume":"2","author":"Taranalli A","year":"2009","unstructured":"Taranalli A , ThimmaiahN, SrinivasS, SaravananE. Research article, Anti-inflammatory, analgesic and anti ulcer activity of certain thiazolidinones. Asian J. Pharm. Clin. Res.2 (4), 79\u201383 (2009).","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"1","key":"e_1_3_3_26_1","first-page":"63","article-title":"Synthesis and anti-inflammatory activity of some novel biphenyl-4-carboxylic acid 5-(arylidene)-2-(aryl)-4-oxothiazolidin-3-yl amides","volume":"67","author":"Deep A","year":"2010","unstructured":"Deep A , JainS, SharmaPC. Synthesis and anti-inflammatory activity of some novel biphenyl-4-carboxylic acid 5-(arylidene)-2-(aryl)-4-oxothiazolidin-3-yl amides. Acta Pol. Pharm.67 (1), 63\u201367 (2010).","journal-title":"Acta Pol. Pharm."},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2011.10.029"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm701496h"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(02)00518-7"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2015.10.047"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2015.11.001"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2016.1186018"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.10.001"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2008.0133"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/B978-1-4832-3266-9.50007-4","volume-title":"Screening Method in Pharmacology (Volume 1)","author":"Turner R","year":"1965","unstructured":"Turner R . The organization of screening. In : Screening Method in Pharmacology (Volume 1). SAGE Publishing, CA, USA, 22\u201341 (1965)."},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-111-27849"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/384644a0"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.9"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc-2017-0115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:51:32Z","timestamp":1716493892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc-2017-0115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":36,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.4155\/fmc-2017-0115"],"URL":"https:\/\/doi.org\/10.4155\/fmc-2017-0115","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}